Introduction {#Sec1}
============

Magnetic resonance imaging (MRI) has become an important imaging modality in the diagnostic workup of breast cancer patients. Breast MRI is the most accurate method for detecting breast cancer, with a reported sensitivity and specificity of 90 % \[95 % confidence interval (CI) 88--92 %\] and 72 % (95 % CI 67--77 %), respectively \[[@CR1]\]. Breast MRI could be indicated for screening in high-risk patients (i.e. BRCA mutations), in cases where multiple tumour foci are suspected, and for evaluation of the effects of neoadjuvant chemotherapy \[[@CR2], [@CR3]\]. On MRI morphology, enhancement characteristics and signal intensity time curves are mostly used to differentiate between benign and malignant lesions. However, breast MRI specificity is only moderate, resulting in many false-positive findings \[[@CR1]\]. Several studies have demonstrated a positive correlation between breast cancer and increased breast vascularity \[[@CR4]--[@CR8]\]. Nevertheless, these studies were not all able to improve the specificity of the MRI by using this information. However, a study from Schmitz et al. showed an increased specificity from 74 % to 87 % when adding vascular maps as a parameter, without affecting the sensitivity \[[@CR9]\].

With respect to breast MRI, most researchers use one of the two following methods to assess changes in vascularity in the presence of malignancy. The first method focuses on prominent vessels leading to an enhanced lesion, the so-called adjacent vessel sign (AVS) \[[@CR10]\]. The second method consists of imaging the vascularity of the whole breast on both sides with contrast-enhanced MRI \[[@CR8]\]. However, both techniques have shortcomings.

In healthy persons the breast is mainly perfused by the internal mammary artery (IMA) \[[@CR11]\]. It is a paired artery, one running on the left side of the sternum and one on the right side.

We hypothesised that if a malignant lesion is present the cross-sectional area of the IMA and/or internal mammary veins (IMV) on the side of the lesion is increased compared to the healthy side.

Measuring and comparing the left and right IMA and IMV could only be useful if the cross-sectional areas of these vessels in a healthy person without breast malignancy are similar. However, a cadaver study of the IMA and IMV with a small population showed that the cross-sectional area of the right IMA was significantly larger than the left in healthy persons \[[@CR12]\]. Confounders that might be responsible for this difference could probably be detected, such as anatomical variation, breast density and breast volume.

The aim of this study was to investigate whether a significant difference exists between the cross-sectional area of IMA and IMV between the healthy and the malignant side in unilateral breast cancer patients. We further investigated whether this difference is absent in healthy persons and whether the cross-sectional area measurements are reproducible for various readers.

Materials and methods {#Sec2}
=====================

Patients {#Sec3}
--------

In this retrospective analysis, 294 consecutive breast MRI exams were performed in 289 patients during a 3-month period. No power calculation was performed because of the proof of principle concept of this study. Exclusion criteria were history of breast-conserving surgery, mastectomy, free-flap oncoplastic reconstruction, neoadjuvant chemotherapy and patients with bilateral breast cancer. In case of multiple MRI exams of one patient, only the first MRI was included. A single radiologist independently considered all MRI exams for inclusion. A total of 125 MRI exams were excluded (Table [1](#Tab1){ref-type="table"}). During image analysis an additional 34 MRI exams were excluded because the internal mammary artery and vein(s) were inadequately depicted, resulting in the inclusion of 135 patients. Patients were divided into two groups: a healthy control and a malignancy group. Patients with invasive breast cancer or carcinoma in situ were considered as malignant.Table 1Reason for exclusion of patientsPatient exclusion reasonn%Breast-conservating therapy in history6138Mastectomy in history1811Free-flap oncoplastic reconstruction1711Neoadjuvant chemotherapy43Bilateral breast cancer11Benign breast surgery in history53Other1912Insufficient MRI quality3421Total159100

Imaging {#Sec4}
-------

MRI exams were performed at 1.5 T (Philips Healthcare, Best, The Netherlands) using a dedicated bilateral 16-channel breast coil. Breast MRI was performed either before or after tissue sampling. Timing and techniques used during tissue sampling were registered. For this study, a non-enhanced 3D T~2~W TSE sequence was used, which is part of our standard MRI mammography protocol. The following scan parameters were used: Field of view 208 × 369, TR 2,000 ms, TE 205 ms, flip angle 90° in transverse plane and reconstructed voxel size 0.96 × 0.96 × 1.00 mm. This non-enhanced sequence was used because the internal mammary vessels were best visualised on this sequence, compared to the contrast-enhanced subtraction images, which are standard in our breast MRI protocol as well. Additionally, the readers were generally blinded to the presence of breast tumours by choosing this sequence because most cancers cannot be accurately identified on non-enhanced T2-weighted images because of the large overlap of T2 relaxation times in benign and malignant breast lesions. It is well known that contrast enhancement is mandatory for accurate identification of breast cancers \[[@CR13]\]. Coronal planes were reconstructed. Digital mammographies were used for the assessment of the breast density. All digital mammographies were acquired on a dedicated mammography system (Senopgraphe Essential, GE Healthcare, Waukesha, WI, USA).

Histopathology {#Sec5}
--------------

Pathological data of all included patients were gathered. All biopsies and operation specimens were classified by a pathologist according to the World Health Organisation guidelines. For this study, size and type of malignancy were gathered in the database.

Image analysis {#Sec6}
--------------

All MRIs were assessed for regular patient care according to the BI-RADS lexicon. Additional analyses were independently performed by two readers using a dedicated viewing work station. Both readers had similar clinical experience, were not trained in reporting breast MRI and were blinded for all clinical data, including the breast MRI results. First, images were reconstructed in a coronal imaging plane by multiplanar reconstruction (Fig. [2a](#Fig2){ref-type="fig"}). Using this view the anatomical classification of the internal mammary artery and vein(s) was evaluated. It is a paired artery, one running on the left side of the sternum and one on its right side. In combination with the common running vein(s) several anatomical variations are known. The four most frequent variations were standardised by Schwabegger, the so-called Schwabegger classification \[[@CR14]\] (Fig. [1](#Fig1){ref-type="fig"}). Discrepancies on anatomical classification were resolved by consulting a third reader, an expert reader of breast MRIs. Identification of the IMA and IMV was ensured by following the vessels to their origins. Afterwards transverse images were used. The manubrium (Fig. [2b](#Fig2){ref-type="fig"}) was used as a landmark for identifying the second rib. The cross-sectional area of the IMA and IMV(s) was measured in the second and third intercostal space (ICS) below the upper edge of the rib and a so-called "free hand region of interest" was drawn. Intraobserver reproducibility was assessed by one reader. This reader reassessed the cross-sectional area of the IMA in the second ICS in all patients with an appropriate time interval between these analyses of more than 6 months using a different coding for the separate cases to avoid recall bias. Breast density was determined on digital mammography using a semi-automatic threshold technique \[[@CR15]\].Fig. 1Four internal mammary artery and vein patterns as described by Schwabegger. Type 1 (**a**). Type 2 (**b**). Type 3 (**c**). Type 4 (**d**). From: Arnez et al., Br J Plast Surg. 1995 Dec;48(8):540--5Fig. 2An example of recognising the Schwabegger classification and measurement of the cross-sectional area of the internal mammary vessels. In this patient no malignancy was found. **a** Coronal view, determining the Schwabegger classification. The left internal mammary artery and vein are visible. Medial the internal mammary artery (IMA) and lateral the internal mammary vein (IMV). This anatomy is comparable with Schwabegger's type 4. **b** Sagittal view, marking the manubrium. This marker appears automatically in the coronal and transverse slices. **c** Transverse slice; using the marker the second intercostal space is recognised and the cross-sectional area of the internal mammary vessels (*left* and *right arrows*) can be measured

Statistical analysis {#Sec7}
--------------------

The interobserver agreement of anatomical variations was analysed using the unweighted Cohen's kappa coefficient. The intraobserver reproducibility was assessed by calculating the intraclass correlation coefficient (ICC) using the one-way random model. A linear mixed-model analysis was performed to investigate differences between the cross-sectional area of the left and right internal mammary vessels, accounting for the correlation between both cross-sectional area measurements within the same patient. In addition, with the use of this linear mixed model, also a possible correlation between the cross-sectional area of the IMA/IMV and anatomical variation, age, breast volume or breast density was tested. In a linear mixed model, the responses from a subject are thought to be the sum (linear) of so-called fixed and random effects. If an effect affects the population mean, it is fixed. If an effect is associated with a sampling procedure, it is random. With the use of a linear-mixed model, the effects of these fixed and random effects are estimated in one model and adjustments can be made. Therefore it provides a useful approach for analysing a wide variety of data. The Statistical Package for the Social Sciences (SPSS), version 18 (Chicago, Illinois) was used for data collection and statistical analysis. P-values \< 0.05 were considered statistically significant.

Results {#Sec8}
=======

The median age of the control group (*n* = 91) was 50 years (range 19--79) compared to a median of 59 years (range 16--86) in the malignancy group (*n* = 44). The median diameter of all invasive tumours in the malignancy group was 2.20 cm (range 0.45--5.50 cm). Table [2](#Tab2){ref-type="table"} shows the variation in malignancies. In the control group tissue sampling of suspicious lesions was performed in 17 patients (9 core biopsies, 3 stereotactic biopsies, 4 MRI-guided biopsies and 1 fine-needle aspiration cytology). In six patients biopsy was performed before breast MRI and in 11 patients afterwards. Tissue sampling was performed in all 44 patients in the malignant group \[37 core biopsies, 5 stereotactic biopsies (vacuum assisted) and 2 MRI-guided biopsies\]. In 35 patients breast MRI was performed after tissue sampling and in 9 patients before tissue sampling.Table 2Type of malignant lesionType of lesionsn%Ductal carcinoma in situ49Invasive ductal carcinoma2966Lobular carcinoma in situ12Invasive lobular carcinoma614Other malignancy49Total44100

Classification of the anatomy of the IMA and IMV according to Schwabegger resulted in an incidence of type 1, 2, 3 and 4 of 16 (5.9 %), 209 (77.4 %), 2 (0.7 %) and 35 (13.0 %) respectively. Another eight (3.0 %) anatomical variations could not be described with the Schwabegger classification \[[@CR14]\]. For the left side, the readers' interobserver agreement showed a kappa value of 0.716; for the right side the kappa value was 0.728, both indicating good agreement.

Results of cross-sectional area measurements of the IMA and IMV underneath the second and third rib are summarised in Tables [3](#Tab3){ref-type="table"} (control group) and [4](#Tab4){ref-type="table"} (malignancy group) for both readers.Table 3Control groupControl groupObserved mean cross-sectional area (mm^2^) left sideObserved mean cross-sectional area (mm^2^) right sideAdjusted difference (mm^2^)PSurface artery ICS 2Reader 14.26 (1.99−12.41)4.36 (2.08−11.06)0.120.298Reader 24.32 (1.02−7.93)4.54 (2.15−8.31)0.210.058Surface vein ICS 2Reader 13.35 (1.88−6.74)3.51 (1.97−8.01)0.190.098Reader 23.42 (1.27−9.63)3.69 (1.78−6.14)0.230.052Surface artery ICS 3Reader 13.66 (1.88−7.22)3.78 (1.93−8.88)0.110.340Reader 23.51 (1.97−8.14)3.67 (1.53−6.86)0.150.132Surface vein ICS 3Reader 12.92 (1.48−7.73)3.13 (1.57−6.88)0.200.074Reader 22.73 (1.21−6.21)2.93 (1.22−5.91)0.210.094In the third column the observed means are reported with the minimum and maximum for the left side. In the fourth column the same results are reported for the right side. In the fifth column the adjusted differences between left and right side vessels are reported according to the linear mixed model analysis. *ICS* Intercostal spaceTable 4Malignancy groupMalignancy groupObserved mean cross-sectional area (mm^2^) healthy sideObserved mean cross-sectional area (mm^2^) lesion sideAdjusted difference (mm^2^)PSurface artery ICS 2Reader 14.63 (2.01−13.22)5.94 (2.06−13.53)1.370.000Reader 24.46 (2.19−7.75)5.24 (2.39−10.29)0.810.003Surface vein ICS 2Reader 13.52 (0.26−7.51)4.42 (1.95−13.81)0.900.005Reader 23.44 (1.16−5.71)3.99 (1.86−7.21)0.550.008Surface artery ICS 3Reader 13.99 (2.14−10.07)5.04 (1.92−12.59)1.030.000Reader 23.58 (1.93−6.75)4.08 (2.05−6.34)0.510.007Surface vein ICS 3Reader 13.21 (1.78−7.22)3.92 (1.95−7.83)0.710.002Reader 22.70 (1.38−4.90)3.35 (1.25−6.92)0.660.000In the third column the observed means are reported with the minimum and maximum for the side with no malignancy. In the fourth column the same results are reported for the malignant side. Column 5 shows the result of linear mixed model analysis in terms of adjusted difference in mm^2^. *ICS* Intercostal space

Analysis of the cross-sectional area measurements performed by reader 1 of the IMA and IMV in the control group showed no significant differences between both sides in either the second or third ICS. The measured mean cross-sectional area of the IMA in the second ICS was 4.26 mm^2^ on the left side (range 1.99--12.41) and 4.36 mm^2^ on the right side (2.08--11.06). The adjusted difference between the left and right IMA as result of the linear mixed model analysis was only 0.12 mm^2^ (*p* = 0.298). The cross-sectional area measurement of the IMA in the second ICS was 4.32 mm^2^ on the left side (range 1.02--7.93) and 4.54 mm^2^ on the right side (range 2.15--8.31) measured by reader 2. Also all other measurements of reader 2 confirmed the results of reader 1; no significant differences existed between the two sides.

In the malignancy group, the results of reader 1 showed a significant difference in the cross-sectional area of the IMA and IMV in the second as well as in the third ICS between the healthy and malignant side (see Fig. [3](#Fig3){ref-type="fig"} for an example). The measured mean cross-sectional area of the IMA in the second ICS was 4.63 mm^2^ on the healthy side (range 2.01--13.22) and 5.94 mm^2^ on the malignant side (2.06--13.53). For the IMA in the second ICS, the largest enlargement of an internal mammary vessel was reported with a mean adjusted difference for reader 1 of 1.37 mm^2^ (*p* \< 0.001). The results of reader 2 in the malignancy group showed similar results as reader 1; a significant difference existed in the second as well as in the third ICS between the healthy and malignant side, and the largest enlargement was seen in the IMA in the second ICS (0.81 mm^2^, *p* = 0.003) too. The reproducibility of the cross-sectional area measurements of the IMA in the second ICS by reader 1 proved to be good in all patients (ICC 0.79, 95 % CI 0.65--0.88).

The semi-automatic threshold technique to estimate the breast density of patients showed a median breast density of 24 % with a standard deviation of 16 %. Together with age and anatomical variation, the mixed model analysis showed no significant correlation (all *p* values \> 0.141 for both readers) for left-right differences of the vascular cross-sectional areas, in both the control and malignancy group.

When taking a cutoff point of 3.0-cm tumour diameter, the mean difference of the cross-sectional area in the second ICS for reader 1 was 1.43 mm^2^ in the group with tumours ≤ 3.0 cm compared to 1.89 mm^2^ in the tumours bigger \> 3.0 cm. This difference was not significant.

The sensitivity was 56.4 % (95 % CI 39--72 %) and specificity 85.1 % (95 % CI 75--91 %) after calculating the difference between the cross-sectional area of the left and right IMA in the second ICS on a patient basis and a cutoff point of 1.00 mm^2^ (i.e. a difference \< 1.00 mm^2^ between left and right, no malignancy; when ≥ 1.00 mm^2^, malignant). Calculated positive and negative predictive values were 62 % (95 % CI 45--78 %) and 81.3 % (95 % CI 71--88 %), respectively.

Discussion and further perspectives {#Sec9}
===================================

This study showed that in healthy persons no significant difference existed between the cross-sectional area of the left and right IMA and IMV on MRI. In the presence of malignancy this study showed a significant enlargement in the cross-sectional area of the IMA and IMV on the malignant side. With this knowledge bilateral comparison of the internal mammary vessels evaluated in the second and third ICS might be used as a predictor for the presence or absence of malignancy. Based on these results it seems most appropriate to focus on the IMA. The IMA showed the biggest enlargement of the cross-sectional area compared to the IMV. As the preferred location for the measurement of the cross-sectional area of the IMA the second ICS should be considered. The enlargement of the IMA is more explicit in the second ICS compared to the third ICS.

Increased breast vascularity can be explained by an increased demand for blood flow, providing nutrients for tumour growth \[[@CR16]\]. In 2010 Carbognin et al. reported features of inflammatory breast cancer on MRI. They reported a hypertrophic IMA in 21 % of the patients \[[@CR17]\]. In healthy persons the breast is mainly perfused by the IMA \[[@CR11]\]. The anatomy can vary per side in one person; therefore, comparing the left and right cross-sectional area of the IMA and IMV could be difficult. Another anatomical difference lies in the possible bifurcation of the IMV. This bifurcation occurs mostly below the third rib; using measurements only above this rib solves this problem.

Different imaging modalities were used for imaging increased vascularity, for example, laser Doppler perfusion imaging \[[@CR18]\], positron emission tomography \[[@CR19]\], computed tomography (CT) \[[@CR20]\] and MRI \[[@CR4]--[@CR6], [@CR8], [@CR10], [@CR21]--[@CR23]\]. With respect to MRI, most researchers use one of two methods to assess changes in vascularity in the presence of malignancy. Using the AVS sign, Dietzel et al. reported a sensitivity of 47 % and a specificity of 88 % \[[@CR10]\]. Others compared the vascularity of the whole breast on both sides with contrast-enhanced MRI. The images were assessed according to the number of vessels, the length and maximum transverse diameter \[[@CR8]\]. Only vessels larger than 3 cm in length or larger than 2 mm in diameter were counted. All measurements were summarised and added. A sensitivity of 88 % and a specificity of 82 % were reported for this method by Sardanelli et al. \[[@CR8]\].

The two currently used methods to assess breast vascularity have different shortcomings.

Using whole breast vascularity, every branching vessel has to be considered for counting or not. This is a subjective and time-consuming procedure. Further, whole-breast vascularity assessment is not possible after mastectomy. In addition, it is possible that the diameter of the vessels increases in size, while the number of vessels stays equal \[[@CR20], [@CR24]\].

In contrast to the whole-breast vascularity method, assessment of the AVS is possible after breast-conserving therapy (BCT) and unilateral mastectomy \[[@CR24]\]. However, every intervention in a breast could cause an inflammation response resulting in enlargement of the (local) vessels. This can influence the sensitivity and specificity of the AVS, as Dietzel et al. already mentioned \[[@CR10], [@CR24]\]. They also mentioned the need to investigate the intra- and interobserver variability of the "AVS method", since assessment of the AVS is very subjective \[[@CR10]\].

With our method a couple of the above-mentioned shortcomings can be overcome. The method is not time consuming; only two measurements of the IMA are needed. The single measurement of the IMA on the left and right side takes only 1 min. Furthermore, the measurements in this study were reproducible by two independent readers, indicating only minor interobserver variation. However, measurement of the internal mammary vessels has its shortcomings. First of all, it is not possible in patients who have undergone a coronary artery bypass graft. After unilateral mastectomy it is also not possible to make a reliable left-right comparison of the internal mammary vessels. It is unclear whether tissue sampling in the breast influences the cross-sectional area of the internal mammary vessels because of an inflammation reaction after sampling. In this study, a case mix of patients with and without tissue sampling before breast MRI was included. We assumed that tissue sampling causes only local changes in vascularisation and does not influence the cross-sectional area of the internal mammary vessels. In one of the breast cancer patients, the MRI showed a major vascular "crossover" (see Fig. [4](#Fig4){ref-type="fig"}). A clear connection between the right and left internal mammary artery is visible. In our opinion a left-right comparison was not reliable in this case. This problem does not occur during assessment of vascularisation with the whole-breast vascularity and AVS techniques.Fig. 3An example of the internal mammary vessels in a patient with a unifocal lesion in the right breast. Measurement of the right internal mammary artery showed a cross-sectional area of 9.6 mm2 on the right side and 6.3 mm2 on the left. Histopathology showed an invasive ductal carcinoma, 3.5 cm, grade 2, triple negativeFig. 4Transverse view on contrast-enhanced subtraction image. A clear case of a "crossover". There is a connection between the left breast and the right internal mammary artery

A limitation of this study was the fact that only the internal mammary vessels were investigated, although the breast is supplied by both the IMA and the lateral thoracic artery (LTA). A study by Doughty et al. showed that the IMA perfuses 67 % of the breast and 15 % of the lateral thoracic artery \[[@CR11]\]. However, Grubstein et al. showed that the increased blood supply of the IMA or LTA was dependent on tumour localisation: 87 % of the medial tumours were supplied mainly by the branches of the IMA and 13 % by the branches of the LTA. The lateral tumours were mainly supplied by the IMA in 48 % and by the LTA in 35 %. In 17 % of the lateral tumours no dominant vessel could be determined \[[@CR21]\]. These data suggest that measurement of the IMA is not sufficient in some patients, and measurements of the LTA are needed. However, it would be very difficult to measure the LTA. Because of the anatomy of the LTA a standardised location for measurements is not available so inter- and intraobserver variability will not be as good compared to the measurements of the IMA.

Also, the visualisation of a tumour within the breast could introduce bias in the measurement, i.e. overestimation of the cross-sectional areas at the side of the breast cancer. Ideally, measurements of the vessels should be performed without visualisation of the breast itself. However, this is not possible within our viewing workstations. It is well known that tumour identification on breast MRI depends heavily on the enhancement of tissue. It is very difficult to detect breast cancers on non-enhanced T2-weighted images (only larger tumours can be identified). Also, to introduce this type of bias, the tumour should be located at exactly the level of the second intercostal space to be detected while performing these measurements. We think that these considerations limit the introduction of bias in these measurements.

This study provides new insights into the possibility of using left-right IMA cross-sectional area differences as a possible new predictor for malignancy on MRI. Further research is needed on this topic. A future study should prospectively confirm these retrospective results in a larger cohort. Also the use of a dedicated MR angiographic sequence can be considered to obtain more sufficient MR quality images. In addition, we would suggest evaluating the possible correlation between tumour diameter and cross-sectional vessel enlargement or assessing the differences between various types of breast cancer, i.e. invasive versus in situ cancers. Due to the limited number of malignant cases, we were unable to perform an accurate analysis with respect to this research question. In the end, this study showed differences between both groups, which might aid in improving the specificity of breast MRI. Although this is a plausible assumption, we wish to emphasise that this is only speculative and that this theory should be evaluated in a larger prospective study, especially with the addition of this new parameter to the common used BI-RADS lexicon parameters.

Carla Boetes is deceased.
